Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX3WML
|
||||
| Drug Name |
3-(1H-indol-3-yl)-N-((4-isopropyl-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-yl)methyl)propan-1-amine
|
||||
| Synonyms |
CHEMBL204331
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H29N3O
|
||||
| Canonical SMILES |
CC(C)N1CC(CNCCCc2c[nH]c3ccccc23)Oc4ccccc14
|
||||
| InChI |
InChI=1S/C23H29N3O/c1-17(2)26-16-19(27-23-12-6-5-11-22(23)26)15-24-13-7-8-18-14-25-21-10-4-3-9-20(18)21/h3-6,9-12,14,17,19,24-25H,7-8,13,15-16H2,1-2H3
|
||||
| InChIKey |
VKCUQIFDZDDWJX-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.